Breast Cancer Clinical Trials in Phoenix, AZ

Breast Cancer Clinical Trials in Phoenix, AZ

View the best 10 breast cancer medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Breast Cancer clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for breast cancer in Phoenix, Arizona

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ulixertinib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of University of Alabama in Birmingham, United States.

Proton +1 More

Proton Beam Therapy

Recruiting1 award12 criteria
This trial is testing whether proton therapy or photon therapy is better for treating breast cancer. It will follow patients for side effects, quality of life, and cancer control.
Image of Banner Health/Banner Research in Phoenix, United States.

External Beam Radiation Therapy

Recruiting1 award3 criteria
This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.
Image of Arizona Oncology Associates, PC - HAL in Phoenix, United States.

Fulvestrant +2 More

Estrogen Receptor Antagonist

Recruiting1 awardPhase 2
This trial is for people with solid tumors that make too much HER2 or a different type of HER2. Participants will get tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get fulvestrant. The trial will look at side effects.
Image of Virginia G. Piper Cancer Center Pharmacy - Scottsdale Healthcare ( Site 0089) in Scottsdale, United States.

Carboplatin +3 More

Chemotherapy

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment of pembrolizumab (MK-3475) combined with chemotherapy vs. chemotherapy alone in participants who have triple negative breast cancer.
Image of Palo Verde Hematology Oncology in Glendale, United States.

Capecitabine +2 More

Antimetabolites

Recruiting2 awardsPhase 3
This trial will test if a new combination of drugs is more effective and safer than standard treatments for triple negative breast cancer.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Stereotactic Body Radiotherapy +2 More

Radiation

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of Mid Florida Hematology and Oncology Center in Orange City, United States.

Anastrozole +5 More

Aromatase Inhibitor

Recruiting3 awardsPhase 4
This trial will assess the long-term safety of ribociclib when used in combination with other drugs in participants who have already benefited from the treatment.
Image of Northwestern Medicine Cancer Center in Warrenville, United States.

TOL2506

Hormone Therapy

Recruiting2 awardsPhase 3
This trial tests TOL2506, a treatment that stops ovaries from working, in premenopausal women and men with hormone-sensitive breast cancer. It aims to reduce hormone levels to slow down or stop cancer growth. TOL2506 is a treatment that stops ovaries from working, similar to other ovarian suppression methods.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.